Avid Bioservices Management
Management criteria checks 3/4
Avid Bioservices' CEO is Nick Green, appointed in Jul 2020, has a tenure of 4.42 years. total yearly compensation is $4.48M, comprised of 14.5% salary and 85.5% bonuses, including company stock and options. directly owns 0.35% of the company’s shares, worth $2.79M. The average tenure of the management team and the board of directors is 5.2 years and 5.4 years respectively.
Key information
Nick Green
Chief executive officer
US$4.5m
Total compensation
| CEO salary percentage | 14.5% |
| CEO tenure | 4.4yrs |
| CEO ownership | 0.4% |
| Management average tenure | 5.2yrs |
| Board average tenure | 5.4yrs |
Recent management updates
Recent updates
Is Avid Bioservices (NASDAQ:CDMO) Using Too Much Debt?
Aug 26
Avid Bioservices, Inc. (NASDAQ:CDMO) Surges 43% Yet Its Low P/S Is No Reason For Excitement
Jul 29There's No Escaping Avid Bioservices, Inc.'s (NASDAQ:CDMO) Muted Revenues Despite A 40% Share Price Rise
Mar 07We Think Avid Bioservices (NASDAQ:CDMO) Has A Fair Chunk Of Debt
Feb 28There's No Escaping Avid Bioservices, Inc.'s (NASDAQ:CDMO) Muted Revenues Despite A 39% Share Price Rise
Dec 28Does Avid Bioservices (NASDAQ:CDMO) Have A Healthy Balance Sheet?
Nov 10Calculating The Intrinsic Value Of Avid Bioservices, Inc. (NASDAQ:CDMO)
Oct 15Time To Worry? Analysts Are Downgrading Their Avid Bioservices, Inc. (NASDAQ:CDMO) Outlook
Jun 23Is Avid Bioservices (NASDAQ:CDMO) Using Too Much Debt?
Jun 12Little Excitement Around Avid Bioservices, Inc.'s (NASDAQ:CDMO) Earnings As Shares Take 26% Pounding
May 21Are Investors Undervaluing Avid Bioservices, Inc. (NASDAQ:CDMO) By 49%?
May 12Does Avid Bioservices (NASDAQ:CDMO) Have A Healthy Balance Sheet?
Mar 13Here's Why Avid Bioservices (NASDAQ:CDMO) Has A Meaningful Debt Burden
Nov 10Avid Bioservices GAAP EPS of $0.02 beats by $0.01, revenue of $36.7M beats by $3.26M
Sep 06CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Oct 31 2024 | n/a | n/a | -US$152m |
| Jul 31 2024 | n/a | n/a | -US$144m |
| Apr 30 2024 | US$4m | US$650k | -US$141m |
| Jan 31 2024 | n/a | n/a | -US$18m |
| Oct 31 2023 | n/a | n/a | -US$12m |
| Jul 31 2023 | n/a | n/a | -US$3m |
| Apr 30 2023 | US$6m | US$642k | US$259k |
| Jan 31 2023 | n/a | n/a | US$116m |
| Oct 31 2022 | n/a | n/a | US$119m |
| Jul 31 2022 | n/a | n/a | US$123m |
| Apr 30 2022 | US$6m | US$600k | US$128m |
| Jan 31 2022 | n/a | n/a | US$10m |
| Oct 31 2021 | n/a | n/a | US$9m |
| Jul 31 2021 | n/a | n/a | US$6m |
| Apr 30 2021 | US$3m | US$421k | US$3m |
Compensation vs Market: Nick's total compensation ($USD4.48M) is above average for companies of similar size in the US market ($USD3.24M).
Compensation vs Earnings: Nick's compensation has been consistent with company performance over the past year.
CEO
Nick Green (59 yo)
4.4yrs
Tenure
US$4,475,343
Compensation
Mr. Nicholas Stewart Green, also known as Nick, B.Sc., MBA, has been the President, Chief Executive Officer and Director at Avid Bioservices, Inc. since July 30, 2020. He served as the Chief Executive Offi...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 4.4yrs | US$4.48m | 0.35% $ 2.8m | |
| Chief Financial Officer | 6.4yrs | US$1.44m | 0.13% $ 1.0m | |
| Chief Operations Officer | 5.2yrs | US$883.93k | 0.062% $ 484.3k | |
| VP, General Counsel & Corporate Secretary | 12.5yrs | US$1.03m | 0.10% $ 821.6k | |
| Chief Commercial Officer | 3.2yrs | US$975.87k | 0.040% $ 312.5k |
5.2yrs
Average Tenure
59yo
Average Age
Experienced Management: CDMO's management team is seasoned and experienced (5.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 4.4yrs | US$4.48m | 0.35% $ 2.8m | |
| Independent Chairman | 7.1yrs | US$275.19k | 0.20% $ 1.6m | |
| Independent Director | 5.4yrs | US$245.19k | 0.068% $ 533.6k | |
| Independent Director | 7.1yrs | US$245.19k | 0.057% $ 447.3k | |
| Independent Director | 4yrs | US$245.19k | 0.071% $ 561.0k | |
| Director | 7.1yrs | US$240.19k | 0.23% $ 1.8m | |
| Independent Director | 3.5yrs | US$240.19k | 0.059% $ 464.3k |
5.4yrs
Average Tenure
65yo
Average Age
Experienced Board: CDMO's board of directors are considered experienced (5.4 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/23 00:20 |
| End of Day Share Price | 2024/12/23 00:00 |
| Earnings | 2024/10/31 |
| Annual Earnings | 2024/04/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Avid Bioservices, Inc. is covered by 14 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Matthew Hewitt | Craig-Hallum Capital Group LLC |
| Vernon Bernardino | FBR Capital Markets & Co. |
| Joseph Pantginis | H.C. Wainwright & Co. |